Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists.
We have established structure-activity relationships of novel truncated D-4'-thioadenosine derivatives from D-mannose as potent and selective A(3) adenosine receptor (AR) antagonists. At the human A(3) AR, most of N(6)-substituted analogues showed high potency and selectivity and acted as pure antagonists in a cyclic AMP functional assay. Among compounds tested, 2-chloro-N(6)-3-chlorobenzyl and N(6)-3-chlorobenzyl analogues displayed very high binding affinities (K(i) = 1.66 nM and 1.5 nM, respectively) at the human A(3) AR. Truncated 4'-thioadenosine derivatives studied here are regarded as an excellent template for the design of novel A(3) AR antagonists to act at both human and murine species.
Hou
Xiyan
X
Laboratory of Medicinal Chemistry, College of Pharmacy, Ewha Womans University, Seoul 120-750, Korea.
Pal
Shantanu
S
Choi
Won Jun
WJ
Kim
Hea Ok
HO
Tipnis
Amol
A
Jacobson
Kenneth A
KA
Jeong
Lak Shin
LS
D000241:Adenosine / Q000031:analogs & derivatives* / Q000737:chemistry; D058918:Adenosine A3 Receptor Antagonists; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D015195:Drug Design; D006801:Humans; D043684:Receptor, Adenosine A3 / Q000378:metabolism; D013329:Structure-Activity Relationship; D013872:Thionucleosides / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism
D058918:Adenosine A3 Receptor Antagonists; D043684:Receptor, Adenosine A3; D013872:Thionucleosides; C050070:4'-thioadenosine; D000241:Adenosine
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1612-6
18255292
Curr Med Chem. 2005;12(11):1319-29
15974999
J Med Chem. 2007 Jul 12;50(14):3159-62
17555308
Org Lett. 2006 Sep 14;8(19):4267-70
16956203
Med Res Rev. 2000 Mar;20(2):103-28
10723024
J Med Chem. 2002 Sep 26;45(20):4471-84
12238926
Pharmacol Ther. 2000 Feb;85(2):55-75
10722120
Nat Rev Drug Discov. 2006 Mar;5(3):247-64
16518376
Bioorg Med Chem Lett. 2006 Feb;16(3):596-601
16289820